COLUMBIA, Md. – Shimadzu Scientific Instruments will present new applications for ultra-fast mass spectrometry (UFMS) at ASMS 2011 in Denver. Data presented will showcase the application of UFMS with Shimadzu’s LCMS-8030 triple quadrupole mass spectrometer to pharmaceuticals, environmental, food safety, forensics, metabolomics, therapeutic drug monitoring and natural products.

UFMS delivers speed without sacrificing sensitivity, resolution or mass range. When coupled with the chromatographic resolving power of the Nexera UHPLC, Shimadzu’s LCMS-8030 triple quadrupole mass spectrometer delivers UFMS solutions that accelerate workflows and achieve ultra-fast speed while overcoming common issues such as loss of sensitivity, poor reproducibility and cross-talk.

With current trends moving toward higher pressures and faster operating speeds for greater throughput, the LCMS-8030’s exceptional scan speed of 15,000 u/sec and ability to perform 500 different MRM measurements per second, enable researchers to fully appreciate the capabilities of UHPLC.

“Typically, improvements in measurement speed require sacrifices in sensitivity or resolution,” said Christopher Gilles, LCMS product manager at Shimadzu Scientific Instruments. “But with the UFMS platform from Shimadzu, data quality is not compromised, enabling researchers to detect an increasing number of target analytes with greater sensitivity and in more samples than ever before, at a faster rate.”

For more information about the LCMS-8030, visit https://www.ssi.shimadzu.com/8030.

About Shimadzu Scientific Instruments Inc.

Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corporation, headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $2 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. The Analytical Division is one of the world’s largest manufacturers of analytical instrumentation and environmental monitoring equipment. In 1975, SSI corporate

headquarters was established in Columbia, Md. to provide analytical solutions to laboratories in North, Central and parts of South America. In the U.S., SSI has a network of more than 50 locations providing local and regional sales, service, and technical support.

About CovalX AG

CovalX AG was founded in 2005 and is headquartered in Schlieren, Switzerland with the vision to become the leading provider of technology and services in the field of High-Mass MALDI analysis for intact proteins and protein interactions. With support offices in Europe, North America and Japan, CovalX is a global company offering leading product and services for major pharmaceutical companies, as well as academic laboratories. CovalX is a fast-growing company, developing innovative analysis solutions for the characterization of therapeutic proteins and protein interactions for the life science industry.